ABOUT US Our mission

We develop and deliver high quality market access, pricing health economics & outcomes research solutions that maximise the value of health care interventions for our clients and result in reimbursed access to those health care interventions by patients with (ultra-rare) diseases who need them. We support our community and create meaningful relationships with all those around us.

At SYNEVi we are committed to optimising access to health care interventions for patients by providing market access, health economics and outcomes research solutions to the pharmaceutical, nutrition and health care industries.

To maximise and maintain the value of health care interventions throughout their lifecycle, SYNEVi also provides pricing, risk-sharing arrangements and managed access program solutions.

The consultants at SYNEVi have all the necessary disciplines with extensive local Australian and global in-house pharmaceutical company and/or academic experience to meet client’s needs. Long-standing relationship with relevant health authorities as well as insight into the payer requirements allows us to offer an extended level of market access and pricing support.

SYNEVi has a social responsibility to the community in which it works. One or more charities and/or causes are therefore supported by SYNEVi each year.

WHY SYNEVI Our experience

With an emphasis on ultra-rare diseases, SYNEVi has a wealth of experience across wide range of therapeutic areas and several different funding mechanisms:

Our expertise in rare diseases has provided SYNEVi with the unique ability to work with small and multiple datasets to demonstrate comparative efficacy and safety of the health care intervention, develop clinically appropriate and technically robust economic models as well as design and implement pricing strategies, risk-sharing arrangements and managed access programs.

OUR NETWORK Global reach

SYNEVi is a member of the MINERVA Health Economics Network, an international consortium of independent leaders in the field of health economics, health technology assessment and outcomes research.

Founded in 2008, the members of MINERVA have a wealth of experience in health economics and outcomes research as well as deep knowledge of issues concerning local reimbursement and market access. MINERVA’s members have extensive expertise in successful pricing and reimbursement, including the procedures, applicable laws, and regulations, as well as optimal reimbursement strategies in each country.

MINERVA has a network of collaborators around the world and has longstanding relationships with key healthcare policy and decision makers in all the countries that are represented in the network. The clients of MINERVA encompass virtually every biopharmaceutical company in the US, Europe, and Asia, as well as numerous medical device companies, health insurers, and governmental authorities, including NICE, HAS, IFLN, WHO, and the World Bank.

MINERVA provides the capacity for global model development as well as local market model adaptation and customisation. The individual members of MINERVA collaborate on many projects, and the group’s rigorous and consistent approach to working ensures that all multinational projects benefit from the network’s country-specific knowledge and expertise.

For further information regarding the MINERVA Health Economics Network, please visit their website www.minerva-network.com

OUR EXPERIENCE SYNEVi services